General information | Number |
---|---|
Gender | |
Male | 18 (24 hips) |
Female | 6 (8 hips) |
Average age (years) | 47.1 ± 10.3 (20–62) |
Pathogeny | |
AFHN | 8 (10 hips) |
SIFHN | 6 (8 hips) |
IFHN | 10 (14 hips) |
Stage | |
Ia | 4 |
Ib | 6 |
Ic | 4 |
IIa | 4 |
IIb | 4 |
IIc | 10 |
Follow-up time (months) | 25.9 ± 15.0 (9.0–55.0) |